Study for safety and usefulness of thoracoscopic segmentectomy using infrared thoracoscope with indocyanine green(ICG)

Not Applicable

• Conditions: lung cancer, lung cancer suspected metastatic lung tumor, metastatic lung tumor suspected

• Registration Number: JPRN-UMIN000030911
• Lead Sponsor: Oncology, Immunology and Surgery, Nagoya City University, Graduate School of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-02-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with a history of side effects from ICG 2. Patients with iodine hypersensitivity 3. Women who are likely to be pregnant and possibly pregnant 4. Patients who are thought to be difficult to undergo thoracoscopic lung segmentectomy depending on the degree of tumor progression 5. Patients judged to be unable to tolerate general anesthesia, such as severe heart disease 6. Patients with infection requiring systemic treatment 7. Patients with fever at surgery 8. Patients who are complicated with psychosis or psychiatric symptoms and are considered difficult to participate in the study 9. Patients who can not obtain consent of transfusion 10. Clinicians decide to exclude from this trial in some reasons

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Morbidity ratio and ratio of identification of segmental plane for ICG infrared thoracoscopic technique

Secondary Outcome Measures

Name	Time	Method
Coincidence ratio of identification of segmental plane between anatomical method, inflation-deflation technique and ICG infrared thoracoscopic technique.